ethylglycylxylidide,
L 86,
L-86,
MEGX,
monoethylglycinexylidide,
monoethylglycinexylidide monohydrochloride,
monoethylglycinexylidide, 3H,1-(14)C-labeled,
Norlidocaine,
Monoethylglycinexylidide,
7728-40-7,
Norlidocaine,
Ethylglycylxylidide,
N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide,
MEGX,
N-Ethylglycinexylidide,
2-Ethylamino-2,6-acetoxylidine,
L 86,
2-Ethylamino-2',6'-acetoxylidide,
UNII-D8Q99HC770,
L-86,
Lidocaine N-de-ethylated metabolite,
2',6'-ACETOXYLIDIDE, 2-(ETHYLAMINO)-,
BRN 2417108,
CHEBI:222828,
WRMRXPASUROZGT-UHFFFAOYSA-N,
D8Q99HC770,
Acetamide, N-(2,6-dimethylphenyl)-2-(ethylamino)-,
omega-(Ethylamino)-2',6'-dimethylacetanilide,
N-(2,6-dimethylphenyl)-N(2)-ethylglycinamide,
Nor Lidocaine,
N-Desethyl Lidocaine,
Monoethylglycylxylidide,
Monoethyl Glycinexylidide,
Maybridge1_007633,
AC1L2NF5,
CHEMBL1028,
N1-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide,
3-12-00-02466 (Beilstein Handbook Reference),
MLS001304701,
AC1Q31K9,
SCHEMBL1232491,
HMS563C21,
KS-00002WRB,
DTXSID60228006,
HMS2232E09,
HMS3374F08,
N-(N-Ethylglycyl)-2,6-xylidine,
2-Ethylamino-2',6'-acetoxylidine,
MEGX, >=95% (HPLC),
ZINC2036824,
MFCD00098991,
2-(Ethylamino)-2',6'-acetoxylidide,
2-(Ethylamino)-2',6'-Acetoxylidine,
AKOS005082288,
CCG-252913,
MCULE-9888750433,
NE20179,
NCGC00246533-01,
BC228363,
LS-13913,
SMR000752507,
Monoethylglycinexylidine, analytical standard,
FT-0636579,
EN300-90184,
1G-010,
A19162,
C16561,
N-(2,6-dimethylphenyl)-N~2~-ethylglycinamide,
.omega.-(Ethylamino)-2',6'-dimethylacetanilide,
2-(ethylamino)-N-(2,6-dimethylphenyl)ethanamide,
N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide #,
Z46193731,
Acetamide, N-(2,6-dimethylphenyl)-2-(ethylamino)- (9CI),
CID24415,
C12-H18-N2-O,
monoethylglycinexylidide monohydrochloride,
|O-Ethylamino-2',6'-dimethyl-acetanilide,
N-(2,6-dimethylphenyl)-2-ethylaminoacetamide,
monoethylglycinexylidide, 3H,1-(14)C-labeled,
C001173,